1994
DOI: 10.1006/geno.1994.1297
|View full text |Cite
|
Sign up to set email alerts
|

Characterization of a de Novo 43-bp Deletion of the Gsα Gene (GNAS1) in Albright Hereditary Osteodystrophy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
19
0
1

Year Published

1997
1997
2010
2010

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 46 publications
(20 citation statements)
references
References 0 publications
0
19
0
1
Order By: Relevance
“…The R231H mutation was reported previously . Data for mutations were derived from the following references (Ahmed et al 1998;Farfel et al 1996;Fischer et al 1998;Iiri et al 1994;Miric et al 1993;Oude-Luttikhuis et al 1994;Pattern et al 1990;Schwindinger et al 1994;Shapira et al 1996;Warner et al 1997Warner et al , 1998Weinstein et al 1990Weinstein et al , 1992Yu et al 1995Yu et al , 1999 NA, Not available; PTH, parathyroid hormone; TRH, thyroidstimulating hormone (TSH) releasing hormone; T4, thyroxine; T3, triiodothyronine a PTH infusion test was performed using bolus synthetic PTH-(1-34), at 100 U/m 2 . Basal levels are the mean urinary cyclic (c)AMP (nmol/h) and urinary phosphate-to-creatine ratio for two urine samples taken in the 2 h before the administration of PTH.…”
Section: Patientmentioning
confidence: 99%
“…The R231H mutation was reported previously . Data for mutations were derived from the following references (Ahmed et al 1998;Farfel et al 1996;Fischer et al 1998;Iiri et al 1994;Miric et al 1993;Oude-Luttikhuis et al 1994;Pattern et al 1990;Schwindinger et al 1994;Shapira et al 1996;Warner et al 1997Warner et al , 1998Weinstein et al 1990Weinstein et al , 1992Yu et al 1995Yu et al , 1999 NA, Not available; PTH, parathyroid hormone; TRH, thyroidstimulating hormone (TSH) releasing hormone; T4, thyroxine; T3, triiodothyronine a PTH infusion test was performed using bolus synthetic PTH-(1-34), at 100 U/m 2 . Basal levels are the mean urinary cyclic (c)AMP (nmol/h) and urinary phosphate-to-creatine ratio for two urine samples taken in the 2 h before the administration of PTH.…”
Section: Patientmentioning
confidence: 99%
“…Taken together, the clinical, molecular and family history data confirm somatic mosaicism. While de novo mutations in GNAS1 have been reported in PHP1a and PPHP patients previously [Luttikhuis et al, 1994;Yu et al, 1995], somatic mosaicism for a GNAS mutation has been not been reported previously in the literature. Aldred et al published one family in which germline mosaicism for a GNAS mutation was ascertained through comparing the maternal haplotype of siblings affected and unaffected with PHP1a.…”
Section: Discussionmentioning
confidence: 79%
“…Exons 2, 4, 5 and 7-13 of the GSa gene were amplified by the polymerase chain reaction (PCR) and specific primer pairs as described before [12,19] [11][12][13][14][15][16][17][18][19][20]27], but no mutation of the Ca gene was found in "only AHO" family [28]. These are distributed throughout the gene with all but one located in exons 2-13.…”
Section: Resultsmentioning
confidence: 99%
“…Mutations of the GSa gene lead to either constitutive activation or loss of function in human diseases [10][11][12][13][14][15][16][17][18][19][20][21][22]. Molecular genetic studies have shown that PHP with AHO can result from heterozygous loss-of-function mutations in the gene encoding the GTP-binding protein GSa.…”
mentioning
confidence: 99%